Cerenome (NASDAQ:CNSY) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.85) by 54.12 percent. This is a 718.75 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $411.000 thousand which missed the analyst consensus estimate of $1.110 million by 62.97 percent. This is a 70.43 percent decrease over sales of $1.390 million the same period last year.